A Study to Evaluate the Pharmacokinetics and Safety Between Single Administration of "BR6002" and Coadministration of "BR6002A" and "BR6002B" Under Fed Conditions in Healthy Adult Volunteers
Clinical trial NCT05959499 · COMPLETED
Trial details
- NCT number
- NCT05959499
- Sponsor
- Boryung Pharmaceutical Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-13
- Primary completion
- 2023-09-12
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.